Research programme: peptide-drug conjugate based diagnostics - PeptiDream
Alternative Names: Diagnostic PDC - PeptiDreamLatest Information Update: 06 Jan 2023
At a glance
- Originator PeptiDream
- Class Drug conjugates; Peptide diagnostics; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 09 Dec 2022 Preclinical trials in Cancer (Diagnosis) in Japan (unspecified route) before December 2022 (PeptiDream pipeline, December 2022)